Literature DB >> 15548600

Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling.

Allan R Albig1, William P Schiemann.   

Abstract

Tubulogenesis by epithelial cells regulates kidney, lung, and mammary development, whereas that by endothelial cells regulates vascular development. Although functionally dissimilar, the processes necessary for tubulation by epithelial and endothelial cells are very similar. We performed microarray analysis to further our understanding of tubulogenesis and observed a robust induction of regulator of G protein signaling 4 (RGS4) mRNA expression solely in tubulating cells, thereby implicating RGS4 as a potential regulator of tubulogenesis. Accordingly, RGS4 overexpression delayed and altered lung epithelial cell tubulation by selectively inhibiting G protein-mediated p38 MAPK activation, and, consequently, by reducing epithelial cell proliferation, migration, and expression of vascular endothelial growth factor (VEGF). The tubulogenic defects imparted by RGS4 in epithelial cells, including its reduction in VEGF expression, were rescued by overexpression of constitutively active MKK6, an activator of p38 MAPK. Similarly, RGS4 overexpression abrogated endothelial cell angiogenic sprouting by inhibiting their synthesis of DNA and invasion through synthetic basement membranes. We further show that RGS4 expression antagonized VEGF stimulation of DNA synthesis and extracellular signal-regulated kinase (ERK)1/ERK2 and p38 MAPK activation as well as ERK1/ERK2 activation stimulated by endothelin-1 and angiotensin II. RGS4 had no effect on the phosphorylation of Smad1 and Smad2 by bone morphogenic protein-7 and transforming growth factor-beta, respectively, indicating that RGS4 selectively inhibits G protein and VEGF signaling in endothelial cells. Finally, we found that RGS4 reduced endothelial cell response to VEGF by decreasing VEGF receptor-2 (KDR) expression. We therefore propose RGS4 as a novel antagonist of epithelial and endothelial cell tubulogenesis that selectively antagonizes intracellular signaling by G proteins and VEGF, thereby inhibiting cell proliferation, migration, and invasion, and VEGF and KDR expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548600      PMCID: PMC545898          DOI: 10.1091/mbc.e04-06-0479

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  67 in total

Review 1.  Clinical translation of angiogenesis inhibitors.

Authors:  Robert Kerbel; Judah Folkman
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

2.  Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity.

Authors:  T Higashijima; J Burnier; E M Ross
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

3.  Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite.

Authors:  Monique C A Duyndam; Saskia T M Hulscher; Elsken van der Wall; Herbert M Pinedo; Epie Boven
Journal:  J Biol Chem       Date:  2002-12-13       Impact factor: 5.157

4.  Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs.

Authors:  Yoshiko Yasuda; Yoshihiko Fujita; Seiji Masuda; Terunaga Musha; Koichi Ueda; Hayahito Tanaka; Hiroyoshi Fujita; Takuya Matsuo; Masaya Nagao; Ryuzo Sasaki; Yukio Nakamura
Journal:  Carcinogenesis       Date:  2002-11       Impact factor: 4.944

Review 5.  Emerging role of endothelin-1 in tumor angiogenesis.

Authors:  Anna Bagnato; Francesca Spinella
Journal:  Trends Endocrinol Metab       Date:  2003-01       Impact factor: 12.015

6.  Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins).

Authors:  T Higashijima; S Uzu; T Nakajima; E M Ross
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

7.  KDR stimulates endothelial cell migration through heterotrimeric G protein Gq/11-mediated activation of a small GTPase RhoA.

Authors:  Huiyan Zeng; Dezheng Zhao; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2002-09-19       Impact factor: 5.157

8.  Erythropoietin and VEGF exhibit equal angiogenic potential.

Authors:  Kai Jaquet; Korff Krause; Mona Tawakol-Khodai; Stefan Geidel; Karl-Heinz Kuck
Journal:  Microvasc Res       Date:  2002-09       Impact factor: 3.514

Review 9.  Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system.

Authors:  Thomas Wieland; Clemens Mittmann
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

10.  Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.

Authors:  William P Schiemann; Diana Rotzer; Waither M Pfeifer; Edi Levi; Kanti R Rai; Petra Knaus; Marshall E Kadin
Journal:  Cancer Detect Prev       Date:  2004
View more
  28 in total

1.  Small molecule inhibitors of arginyltransferase regulate arginylation-dependent protein degradation, cell motility, and angiogenesis.

Authors:  Sougata Saha; Junling Wang; Brian Buckley; Qingqing Wang; Brenda Lilly; Mikhail Chernov; Anna Kashina
Journal:  Biochem Pharmacol       Date:  2012-01-18       Impact factor: 5.858

Review 2.  The N-end rule pathway and regulation by proteolysis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

3.  RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury.

Authors:  Andrew M Siedlecki; Xiaohua Jin; Winston Thomas; Keith A Hruska; Anthony J Muslin
Journal:  Kidney Int       Date:  2011-03-16       Impact factor: 10.612

4.  RGS4 controls renal blood flow and inhibits cyclosporine-mediated nephrotoxicity.

Authors:  A Siedlecki; J R Anderson; X Jin; J R Garbow; T S Lupu; A J Muslin
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

5.  Zebrafish G protein gamma2 is required for VEGF signaling during angiogenesis.

Authors:  Tinchung Leung; Hui Chen; Anna M Stauffer; Kathryn E Giger; Soniya Sinha; Eric J Horstick; Jasper E Humbert; Carl A Hansen; Janet D Robishaw
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

6.  Regulator of g protein signaling 3 modulates wnt5b calcium dynamics and somite patterning.

Authors:  Christina M Freisinger; Rory A Fisher; Diane C Slusarski
Journal:  PLoS Genet       Date:  2010-07-08       Impact factor: 5.917

7.  Lipocalin-7 is a matricellular regulator of angiogenesis.

Authors:  Leslie J Brown; Mariam Alawoki; Mary E Crawford; Tiffany Reida; Allison Sears; Tory Torma; Allan R Albig
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

8.  The N-end rule pathway is a sensor of heme.

Authors:  Rong-Gui Hu; Haiqing Wang; Zanxian Xia; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205

9.  miR-126 regulates angiogenic signaling and vascular integrity.

Authors:  Jason E Fish; Massimo M Santoro; Sarah U Morton; Sangho Yu; Ru-Fang Yeh; Joshua D Wythe; Kathryn N Ivey; Benoit G Bruneau; Didier Y R Stainier; Deepak Srivastava
Journal:  Dev Cell       Date:  2008-08       Impact factor: 12.270

10.  Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system.

Authors:  Sophie Javerzat; Mélanie Franco; John Herbert; Natalia Platonova; Anne-Lise Peille; Véronique Pantesco; John De Vos; Said Assou; Roy Bicknell; Andreas Bikfalvi; Martin Hagedorn
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.